➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
Express Scripts
Baxter
McKesson
Johnson and Johnson

Last Updated: August 8, 2020

DrugPatentWatch Database Preview

BUMEX Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Bumex, and when can generic versions of Bumex launch?

Bumex is a drug marketed by Validus Pharms and is included in two NDAs.

The generic ingredient in BUMEX is bumetanide. There are six drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the bumetanide profile page.

US ANDA Litigation and Generic Entry Outlook for Bumex

A generic version of BUMEX was approved as bumetanide by HOSPIRA on October 31st, 1994.

  Start Trial

Drug patent expirations by year for BUMEX
Pharmacology for BUMEX

US Patents and Regulatory Information for BUMEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Validus Pharms BUMEX bumetanide INJECTABLE;INJECTION 018226-001 Feb 28, 1983 DISCN Yes No   Start Trial   Start Trial   Start Trial
Validus Pharms BUMEX bumetanide TABLET;ORAL 018225-003 Jun 14, 1985 AB RX Yes No   Start Trial   Start Trial   Start Trial
Validus Pharms BUMEX bumetanide TABLET;ORAL 018225-002 Feb 28, 1983 AB RX Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for BUMEX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Validus Pharms BUMEX bumetanide TABLET;ORAL 018225-001 Feb 28, 1983   Start Trial   Start Trial
Validus Pharms BUMEX bumetanide INJECTABLE;INJECTION 018226-001 Feb 28, 1983   Start Trial   Start Trial
Validus Pharms BUMEX bumetanide TABLET;ORAL 018225-002 Feb 28, 1983   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Merck
Medtronic
Baxter
Mallinckrodt
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.